Cardiovascular Diseases Clinical Trial
Official title:
Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)
To determine factors beyond obesity which contribute to diabetes and cardiovascular risk in Mexicans and Mexican Americans. To test the hypothesis that at any given level of adiposity Mexican Americans will be more insulin resistant than Anglos and that the insulin resistance in Mexican Americans is proportional to the degree of Native American ancestry.
BACKGROUND:
The present study was preceded by the earlier San Antonio Heart Study 1 supported under this
grant. The San Antonio Heart Study 1 was a population-based survey of diabetes and
cardiovascular risk factors in Mexican American and non-Hispanic whites conducted from 1979
to 1982. Participants included all men and non-pregnant women ages 24 to 64, who resided in
households randomly sampled from three socio-culturally distinct neighborhoods of San
Antonio. The low-income barrio residents were almost exclusively traditional
Mexican-Americans. The middle-income neighborhood was ethnically balanced with equal numbers
of Mexican Americans and Anglos whereas the upper income suburb was approximately 90 percent
Anglo. Risk factors measured included obesity, glucose intolerance, hypertriglyceridemia,
low levels of high density lipoprotein cholesterol, and blood pressure. The total number of
people who were examined medically was 2,386, divided as follows: 1,288 Mexican Americans;
929 Anglos; and 169 other Hispanics such as Cubans. The San Antonio Heart Study was designed
to test the hypothesis that as Mexican Americans became progressively more affluent and
acculturated to 'mainstream' United States culture, they would gradually lose their diabetic
pattern of cardiovascular risk factors of obesity, diabetes, and hypertriglyceridemia.
DESIGN NARRATIVE:
Beginning in 1979, a random sample was conducted to select participants. Sampling was
performed to match the two groups on obesity, thereby enabling an analysis of the ethnic
differences in diabetes and cardiovascular risk factors independent of the confounding
effects of obesity. For those selected, an interview and medical examination were conducted
in a mobile clinic. The interview consisted of a personal and family history of diabetes and
cardiovascular risk, knowledge of and attitudes towards cardiovascular risk factors, dietary
questionnaire, Rose Angina questionnaire, intermittent claudication questionnaire, and
medication history. The medical examination consisted of anthropometric measurements, plasma
glucose, plasma insulin, hemoglobin, serum cholesterol, triglyceride, HDL, LDL, and VLDL,
genetic markers, blood pressure, skin color and electrocardiogram. It was estimated that 400
diabetics would be available over the four years of the study to permit a Diabetic Recall
Examination. The purpose of the Diabetic Recall Examination was to assess possible end-organ
complications of diabetes involving the eye, kidney, peripheral and autonomic nervous
systems, and the peripheral vascular system. The assessment provided baseline data on
diabetics which was used for a prospective incidence study. Beginning in 1989, a prevalence
survey of type II diabetes mellitus and cardiovascular risk factors was conducted in a
low-income barrio in Mexico City. Information collected on this population included
demographic data, socioeconomic status, level of acculturation, medical history, diet,
exercise, and smoking. The physical examination included measurements of blood pressure,
obesity, body fat distribution, and skin color. The laboratory examination included
measurements of lipids and lipoproteins, oral glucose tolerance tests, fasting and
post-glucose load insulin concentrations and genetic markers.
Beginning in FY 1989, Michael Stern and associates carried out an epidemiologic study of
type II diabetes mellitus and cardiovascular risk factors in a low-income barrio of Mexico
City and compared results to those obtained in San Antonio. They recruited and interviewed
subjects for data on demographics, socioeconomic status, level of acculturation, medical
history, health habits including diet, physical exercise, and smoking. The physical
examination included blood pressure, obesity, body fat distribution, skin color, the latter
to estimate percent Native American genetic admixture. The laboratory examination included
measurements of lipids and lipoproteins, an oral glucose tolerance test to determine the
prevalence of diabetes according to the National Diabetes Data Group criteria, fasting and
post-glucose load insulin concentrations, and genetic markers.
The study was renewed in 1996 through August, 2001. A 3.25 year followup examination (FU1)
of a cohort of 2,296 Mexican men and women, ages 35-64 years at baseline, was completed. The
cohort was re-examined at 3.25-year intervals (6.5 years (FU2) and 9.75 years (FU3) after
baseline). The investigators tested the hypothesis that different risk factors would prevail
in the early (more than 3.25 years prior to conversion to diabetes) than in the late (3.25
years or less prior to conversion) prediabetic period. They hypothesized that in the early
prediabetic period risk factors associated with the Insulin Resistance Syndrome would
predominate, i.e., high "specific" insulin concentration (measured by a specific
immunoassay), hypertriglyceridemia, low HDL-cholesterol, and hypertension, whereas in the
late prediabetic period factors associated with insulin secretory failure, i.e., increased
proinsulin and low "specific" insulin, would predominate.
Michael Stern and associates assessed carotid wall thickness by ultrasonography on all
subjects at FU1 and planned to repeat this at FU2. They measured advanced glycation
endproduct (AGE)-modified apolipoprotein B and a panel of inflammatory risk factors (serum
albumin, serum amyloid A, alpha1-acid glycoprotein, and C-reactive protein) on stored
contingency specimens from baseline and FU1 in order to determine if these factors predicted
accelerated thickening of carotid walls and/or the development of type II diabetes. They
also quantified the extent to which carotid wall thickness and ECG documented myocardial
infarction preceded clinical diabetes as predicted by the "common soil" hypothesis, i.e.,
the hypothesis that both type II diabetes and atherosclerosis have common genetic and
environmental antecedents.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|